October 27, 2025 · Form 4 insider transaction
Rowland Charles A Jr sold 16,000 shares of Viking Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.